SCHEMBL19929

SCHEMBL19929

Cn1ccc(N)nc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27952255 1.00 PIK3CB (0.41)
Iodide SCHEMBL29172953 0.98 PIK3CB (0.40)
Hydrochloric Acid SCHEMBL6853659 0.98 PIK3CB (0.40)
Phosphoric Acid SCHEMBL7818662 0.90 FGFR1 (0.43)
Sulfurous Acid SCHEMBL5695173 0.90 LMNA (0.36)
Phosphoric Acid SCHEMBL28113088 0.90 FGFR1 (0.43)
Cytosine SCHEMBL1673111 0.84 BRD4 (0.40)
SCHEMBL28823314 0.79 KDM4E (0.32)
SCHEMBL23128404 0.77
SCHEMBL4661802 0.77 ADORA2A (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11212 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144896-A1 MODIFIED CPG DINUCLEOTIDES FOR RECOMBINANT VIRAL VECTOR PRODUCTION SIREN BIOTECHNOLOGY, INC. (US) 2026-05-28 US claimed
CN-122070361-A Method for amplifying methylated DNA 辛戴克斯生物有限公司 2026-05-19 CN claimed
WO-2026102107-A1 METHODS FOR DETECTING SOMATIC VARIANTS GUARDANT HEALTH, INC. (US) 2026-05-15 WO claimed
WO-2026102110-A1 INDIVIDUALIZED MRD ASSAY TYPE SELECTION TO MAXIMIZE PER PATIENT SENSITIVITY BASED ON COMPREHENSIVE TUMOR VARIANT PROFILING GUARDANT HEALTH, INC. (US) 2026-05-15 WO claimed
WO-2026087976-A1 METHOD FOR DETECTING CANCER THROUGH CELL-FREE DNA METHYLATION PATTERNS IN SUBJECT AND DIAGNOSTIC DEVICE THEREFOR STRAND LIFE SCIENCES PRIVATE LIMITED (IN) 2026-04-30 WO claimed
EP-4724606-A1 METHODS, COMPOSITIONS, AND KITS FOR PREPARING LIBRARY AND TARGETED SEQUENCING GeneFirst Ltd. (GB) 2026-04-15 EP claimed
EP-4720297-A2 OPA1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES Stoke Therapeutics, Inc. (US) 2026-04-08 EP claimed
US-12584168-B2 Sample preparation method OXFORD NANOPORE TECHNOLOGIES PLC (GB) 2026-03-24 US claimed
US-20260028668-A1 DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2026-01-29 US claimed
US-20260015673-A1 USING NUCLEIC ACID SIZE RANGE FOR NONINVASIVE CANCER DETECTION UNIV HONG KONG CHINESE (HK) 2026-01-15 US claimed
US-5386030-A Chemical intermediates INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCE OF THE CZECH REPUBLIC (CZ) 1995-01-31 US claimed
WO-1994021240-A2 SUPERPARAMAGNETIC PARTICLES, PROCESS FOR PRODUCING THE SAME AND THEIR USE SILICA GEL GES.M.B.H (DE) 1994-09-29 WO claimed
EP-0463043-B1 METHOD FOR STABILIZING THE HYBRIDIZATION OF COMPLEMENTARY POLYNUCLEOTIDE SEQUENCES OPALE BIOTECHNOLOGY (FR) 1994-05-18 EP claimed
US-5160725-A Contrast agent for diagnostic imaging, polyethylene glycol phosphates and carboxylates as stabilizers SILICA GEL GESELLSCHAFT MBH ADSORPTIONS-TECHNIK, APPARATEBAU (DE) 1992-11-03 US claimed
EP-0284549-B1 MAGNETIC FLUID COMPOSITIONS Silica Gel Ges.mbH Absorptionstechnik, Apparatebau (DE) 1992-07-15 EP claimed
WO-1990010713-A1 METHOD FOR STABILIZING THE HYBRIDIZATION OF COMPLEMENTARY POLYNUCLEOTIDE SEQUENCES OPALE BIOTECHNOLOGY (FR) 1990-09-20 WO claimed
EP-0174879-B1 POLYNUCLEOTIDES COVALENTLY BONDED TO A SOLID SUPPORT, AND METHOD FOR THEIR PREPARATION INSTITUT PASTEUR (FR) 1990-09-19 EP claimed
EP-0375722-A1 CHEMICAL PROCESS FOR OBTAINING LABELLED OLIGONUCLEOTIDES AND BIOLOGICAL APPLICATIONS INSTITUT PASTEUR (FR) 1990-07-04 EP claimed
WO-1989001941-A1 CHEMICAL PROCESS FOR OBTAINING LABELLED OLIGONUCLEOTIDES AND BIOLOGICAL APPLICATIONS INSTITUT PASTEUR (FR) 1989-03-09 WO claimed
EP-0284549-A2 Magnetic fluid compositions Silica Gel Ges.mbH Absorptionstechnik, Apparatebau (DE) 1988-09-28 EP claimed